Stay updated on ELAD Safety and Efficacy in AILD Clinical Trial
Sign up to get notified when there's something new on the ELAD Safety and Efficacy in AILD Clinical Trial page.

Latest updates to the ELAD Safety and Efficacy in AILD Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays a government funding lapse notice and updates the version label to v3.4.1, while removing the previous v3.4.0 label. These changes do not modify core study information such as eligibility, endpoints, or results; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check8 days agoChange DetectedAdditions: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0; Deletions: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.3.4 is now shown, replacing the previous v3.3.3. This appears to be a minor page version update with no changes to the study content or data.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded the Locations section with numerous study sites (Arkansas, California, Florida, Georgia, Illinois, Maryland, Massachusetts, Minnesota, Missouri, New Jersey, New York, Ohio, Pennsylvania, Texas, Virginia, Wisconsin, Styria, Bavaria, Madrid, England, Scotland) and updated the revision to v3.3.3; removed the HHS Vulnerability Disclosure section and older location entries.SummaryDifference1%

- Check72 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page removed a general government funding/status notice; the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to ELAD Safety and Efficacy in AILD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELAD Safety and Efficacy in AILD Clinical Trial page.